The use of glucagon during colonoscopy reduced cecal intubation time but did not affect other parameters of efficacy, according to the results of a new meta-analysis presented at the 2020 virtual meeting of the American College of Gastroenterology (abstract P1183).
Glucagon is an antispasmodic drug that has been associated with improved colonoscopy outcomes, but the exact effects of the drug remain unknown. The purpose of the meta-analysis was to determine its true role in colonoscopy, noted